Israel - English - Ministry of Health

sanofi israel ltd - clobazam - tablets - clobazam 10 mg - clobazam - clobazam - frisium is a 1,5-benzodiazepine indicated for the short-term relief (2 – 4 weeks) only of anxiety in adult patients that is severe, disabling or subjecting the individual to unacceptable distress, occurring alone or in association with insomnia or short term psychosomatic, organic or psychotic illness.the use of frisium to treat short-term “mild” anxiety is inappropriate and unsuitable.

Israel - English - Ministry of Health

sanofi israel ltd - sarilumab - solution for injection - sarilumab 131.6 mg / 1 ml - sarilumab - kevzara in combination with methotrexate (mtx) is indicated for the treatment of moderately to severely active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). kevzara can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate.

Israel - English - Ministry of Health

sanofi israel ltd - sarilumab - solution for injection - sarilumab 175 mg / 1 ml - sarilumab - kevzara in combination with methotrexate (mtx) is indicated for the treatment of moderately to severely active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). kevzara can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate.kevzara is indicated for treatment of adult patients with polymyalgia rheumatica who cannot tolerate corticosteroid taper

Israel - English - Ministry of Health

sanofi - aventis israel ltd - insulin lispro - solution for injection - insulin lispro 100 u/ml - insulin lispro - admelog is indicated for the treatment of adults with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. admelog is also indicated for the initial stabilisation of diabetes mellitus.

Israel - English - Ministry of Health

sanofi - aventis israel ltd - lixisenatide - solution for injection - lixisenatide 10 mcg / 0.2 ml - lixisenatide - for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Israel - English - Ministry of Health

sanofi - aventis israel ltd - valproic acid; valproic acid as sodium - tablets prolonged release - valproic acid 145 mg; valproic acid as sodium 333 mg - valproic acid - treatment of generalized or partial epilepsy secondary epilepsy and mixed forms of epilepsy. bipolar disorders: treatment and/or prevention of acute manic episodes in the context of bipolar disorders.

Israel - English - Ministry of Health

sanofi israel ltd - metronidazole as benzoate - suspension - metronidazole as benzoate 25 mg/ml - metronidazole - metronidazole - infections caused by anaerobic bacterias, amebiosis, lambliasis and trichomonas.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate; colecalciferol; cholecalciferol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - risedronate sodium; calcium carbonate; colecalciferol; cholecalciferol -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - lixisenatide -